Cargando…
The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles
BACKGROUND: GnRHa and hCG are both used for oocyte maturation and ovulation triggering. However, GnRHa have a shorter half-life than hCG, which leads to luteal phase deficiency. Letrozole (LE) has been found to improve the luteal function. Thus, the choice of triggering strategy can be different in...
Autores principales: | Chen, Li, Xi, Qianwen, Jiang, Shutian, Gao, Yining, Long, Hui, Wang, Yao, Kuang, Yanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347861/ https://www.ncbi.nlm.nih.gov/pubmed/37442967 http://dx.doi.org/10.1186/s12884-023-05835-8 |
Ejemplares similares
-
The Effect of Spontaneous LH Surges on Pregnancy Outcomes in Patients Undergoing Letrozole-HMG IUI: A Retrospective Analysis of 6,285 Cycles
por: Jiang, Shutian, et al.
Publicado: (2022) -
Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
por: Xia, Min, et al.
Publicado: (2021) -
Chorionic Gonadotrophin, ACTH, and the Adrenal-Hyaluronidase Relationship
por: Opsahl, Jeanette C., et al.
Publicado: (1951) -
Enhancement of human chorionic gonadotrophin production by antimetabolites.
por: Browne, P., et al.
Publicado: (1982) -
Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008)